Buprenorphine transdermal skin patch and Plasma-Lyte 56 and Dextrose
Determining the interaction of Buprenorphine transdermal skin patch and Plasma-Lyte 56 and Dextrose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: lvp solution with potassium
Brand name:
Synonyms: Dextrose and Electrolyte No 48
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Platinol
- Buprenorphine transdermal skin patch-Platinol-AQ
- Buprenorphine transdermal skin patch-Plavix
- Buprenorphine transdermal skin patch-Plazomicin
- Buprenorphine transdermal skin patch-Plazomicin Intravenous
- Buprenorphine transdermal skin patch-Plazomicin Sulfate
- Plasma-Lyte 56 and Dextrose-Buprenorphine, Buprenorphine Hydrochloride
- Plasma-Lyte 56 and Dextrose-Buprenorphine/naloxone Oromucosal, Sublingual
- Plasma-Lyte 56 and Dextrose-Buproban
- Plasma-Lyte 56 and Dextrose-Bupropion
- Plasma-Lyte 56 and Dextrose-Bupropion and naltrexone
- Plasma-Lyte 56 and Dextrose-Bupropion Extended-Release Tablets